Utrecht, Netherlands

Martin Stigter



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Martin Stigter

Introduction

Martin Stigter, an innovative inventor based in Utrecht, Netherlands, has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. With a total of four patents to his name, Stigter continues to push the boundaries of medical technology.

Latest Patents

Stigter's most recent patents focus on novel controlled release compositions for interferon-based polyethylene glycol terephthalate (PEGT) and polybutylene terephthalate (PBT) block copolymers. These inventions disclose pharmaceutical compositions designed for the controlled release of relatively toxic active compounds, especially bioactive proteins from the class of interferons. The compositions utilize biodegradable block copolymers and can be provided as injectable microparticles, injectable liquids with potential self-gelling properties, or solid implants. Additionally, the patents include methods for preparing these compositions as well as pharmaceutical kits that incorporate them for various medical applications.

Career Highlights

Throughout his career, Martin Stigter has worked with key companies in the pharmaceutical sector, including Biolex Therapeutics, Inc. and Isotis S.a. His experience in these organizations has undoubtedly contributed to his expertise in the development of innovative pharmaceutical solutions.

Collaborations

Stigter has also collaborated with talented individuals in his field, including Anne Chantal Bechet and Riemke Van Dijkhuizen-Radersma. These professional relationships have facilitated the exchange of ideas and knowledge, further enhancing the impact of his inventions.

Conclusion

Martin Stigter's work exemplifies the spirit of innovation in the pharmaceutical industry. With his latest patents focusing on controlled release technologies, he continues to pave the way for advancements that may significantly improve patient outcomes in the future. His collaborations and career experiences highlight his dedication to pushing forward the boundaries of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…